- Advertisement -

Cambridge University receives $72 million gift for habitat restoration projects across Europe’s land and seas

Arcadia has made a major new philanthropic donation to the University of Cambridge, taking its total support for the Endangered Landscapes & Seascapes Programme...

Involvement of brain peptide dynamics in the pathology of fatty liver disease

Niigata, Japan – The research group of Professor Kamimura in Niigata University have demonstrated the complementary role of peripheral and central nervous system on...

UMB startup releases cutting-edge software platform for pharmaceutical researchers

Pumas-AI, a new University of Maryland, Baltimore (UMB) startup company established by University of Maryland School of Pharmacy (SOP) faculty members Vijay Ivaturi, PhD,...

BioNEST facility opened at MAHE in Manipal for biotechnology start-ups –...

BioNEST caters to biotech entrepreneurs, startups with access to relevant instruments, offers mentorship, access to experts, angels, and regulatory guidance BioNEST caters to biotech entrepreneurs,...

PhoreMost Achieves Target Discovery Milestone with Boehringer Ingelheim

PhoreMost Ltd., a British biopharmaceutical company, announced that their partnership with Boehringer Ingelheim on several projects to find new drug targets has led to...

Human expansion 1,000 years ago linked to Madagascar’s loss of large...

The island of Madagascar—one of the last large land masses colonized by humans—sits about 250 miles (400 kilometers) off the coast of East Africa....

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key tumor defense against...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...

more new items

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...